Intuitive Machines stock climbs on lunar mission plan as McDonald’s edges higher ahead of results

Here are the biggest movers of the day:

Stock gainers:

Coherus BioSciences stock
CHRS,
-3.65%
rose 17% as the Food and Drug Administration approved its treatment for nasopharyngeal cancer when combined with chemotherapy that it makes with Shanghai Junshi Biosciences.